As a cardiologist, I observe this injustice on a weekly, and sometimes daily, basis. For example, individuals with cholesterol issues, hereditary heart failure and statin intolerance, there is now a class of medication called PCSK9 inhibitors that help lower cholesterol when statins have failed. However, many heart patients, especially those in the African American community, have struggled to obtain access to PCSK9 medication.

We have also witnessed this with heart failure treatments for African American patients. Many patients who qualify with severe congestive heart failure have been denied lifesaving treatments. It is increasingly difficult to serve and protect patients when doctors cannot easily treat patients that are in need.

Read more here.